Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Spanheimer

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Annals of Surgical Oncology|September 10, 2025
Reply to Letter to the Editor: "Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database Analysis," by AltundagSelena J An, Philip M Spanheimer
Annals of Surgical Oncology|March 8, 2012
Management of patients with primary hyperparathyroidism and concurrent thyroid disease: an evolving fieldPhilip M Spanheimer, Ronald J Weigel
Cancer Research|February 1, 2025
In Search of Representative Translational Cancer Model SystemsHannah E Trembath, Philip M Spanheimer
Annals of Surgical Oncology|May 22, 2019
ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent PrognosisPhilip M Spanheimer, Andrea V Barrio
Annals of Surgical Oncology|July 24, 2020
Primary Site Surgery and Survival Impact in Metastatic HER2-Amplified Breast Cancer: Responsible use of Cohort DataRobert W Krell, Philip M Spanheimer
Annals of Surgical Oncology|July 13, 2022
ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2- Breast Cancer?Maire J Amlicke, Philip M Spanheimer
The Lancet. Oncology|October 28, 2022
Breast surgery after neoadjuvant chemotherapy: time for a change?Philip M Spanheimer, Katherine E Reeder-Hayes
Clinical and Translational Science|October 23, 2025
AI-Driven Variant Annotation for Precision Oncology in Breast CancerKriti Shukla, Yue Wang, Philip M Spanheimer, et al.
The Journal of Surgical Research|October 13, 2022
A Review of Immune Checkpoint Blockade for the General SurgeonXavier L Baldwin, Philip M Spanheimer, Stephanie Downs-Canner
Breast Cancer Research and Treatment|April 15, 2023
High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancerRasha T Kakati, Hyunsoo Kim, Austin Whitman, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|September 10, 2025
Reply to Letter to the Editor: "Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database Analysis," by AltundagSelena J An, Philip M Spanheimer
Annals of Surgical Oncology|March 8, 2012
Management of patients with primary hyperparathyroidism and concurrent thyroid disease: an evolving fieldPhilip M Spanheimer, Ronald J Weigel
Cancer Research|February 1, 2025
In Search of Representative Translational Cancer Model SystemsHannah E Trembath, Philip M Spanheimer
Annals of Surgical Oncology|May 22, 2019
ASO Author Reflections: Malignant/Borderline Phyllodes Tumors Without Uniformly Poor Histologic Features Have an Excellent PrognosisPhilip M Spanheimer, Andrea V Barrio
Annals of Surgical Oncology|July 24, 2020
Primary Site Surgery and Survival Impact in Metastatic HER2-Amplified Breast Cancer: Responsible use of Cohort DataRobert W Krell, Philip M Spanheimer
Annals of Surgical Oncology|July 13, 2022
ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2- Breast Cancer?Maire J Amlicke, Philip M Spanheimer
The Lancet. Oncology|October 28, 2022
Breast surgery after neoadjuvant chemotherapy: time for a change?Philip M Spanheimer, Katherine E Reeder-Hayes
Clinical and Translational Science|October 23, 2025
AI-Driven Variant Annotation for Precision Oncology in Breast CancerKriti Shukla, Yue Wang, Philip M Spanheimer, et al.
The Journal of Surgical Research|October 13, 2022
A Review of Immune Checkpoint Blockade for the General SurgeonXavier L Baldwin, Philip M Spanheimer, Stephanie Downs-Canner
Breast Cancer Research and Treatment|April 15, 2023
High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancerRasha T Kakati, Hyunsoo Kim, Austin Whitman, et al.
Pageof 8